[email protected]

01252 375362

01252 375362

  • About Us
    • About Pharmacy Consulting
    • Our Team
    • Work With Us
    • Testimonials
  • Consultancy
    • For Pharmaceutical Wholesalers
    • For Pharmacies
    • Care Quality Commission – CQC
    • Pharmaceutical Manufacturers
    • Medical Devices Consultancy and Training
  • Academy Training
  • Bespoke Training
  • Making Pharmaceuticals Show
  • Our CPD
    • Blog
    • Editorial Items
    • Social Media
  • Contact Us

Online Pharmacy – are patients better with a ‘face to face’?

by Jackie (née Heneghan) Peck | Jun 12, 2014 | Blog, Community Pharmacy, Pharmacy Brands, Regulation

Recent coverage in the Australian community pharmacy press has centred around the benefit and/or potential harm of prescribing and dispensing medicines without a face-to-face consultation.  The discussion raised asked the question whether an online questionnaire is...

Recent MHRA Alerts

by Jackie (née Heneghan) Peck | May 20, 2014 | Blog, Community Pharmacy, Pharmacy Brands, Pharmacy Suppliers

So much for all the wonders and claims of slimming tablets … After investigation, the MHRA has recently issued alerts about a number of products found to have prescription only drug ingredients in them.  All the alerts were raised by the Hong Kong Department of...

Export of medicines in short supply………

by Jackie (née Heneghan) Peck | May 12, 2014 | Blog, Community Pharmacy, Pharmacy Brands, Pharmacy Suppliers

The PSNC is no longer maintaining a list as shortages have become part of every day life in pharmacy now. This posed a question by one of my clients: “Does this mean we can now export anything?” No I said you must not export drugs in short supply and I refereed him to...

RP & GDP Training for WDA(H)

by Jackie (née Heneghan) Peck | May 12, 2014 | Behind the scenes, Blog, Community Pharmacy, Pharmacy Brands, Pharmacy Suppliers, Regulation

RP – Responsible Person relating to MHRA GDP – Good Distribution Practice – the guidelines by which medicine wholesalers must adhere to WDA(H) – Wholesale Distribution Authorisation for Human Use – previously Wholesale Dealer’s...

Out of Specification (OOS) Test Results

by Jackie (née Heneghan) Peck | May 12, 2014 | Behind the scenes, Blog, Pharmacy Suppliers, Regulation

What are Out of Specification results (OOS)?  It seems to be clear enough in the name but I thought I better check it out. One definition is: All test results which fall outside the specifications or acceptance criteria established in drug applications, drug master...
« Older Entries
Next Entries »

Recent Posts

  • MHRA-NICE aligned pathway
  • New regulations for clinical trials
  • Pharmacy Consulting Ltd – Audit Training

Upcoming Courses

  • RP Forum – tbc on 7 April 2026 10:00 am
  • Introduction to Good Distribution Practice Online Training on 10 April 2026 10:00 am
  • Intro to the Responsible Person (import) Role (Online) on 13 April 2026
  • GDP/RP Cogent Gold Standard Online Training on 14 April 2026
  • Active Pharmaceutical Ingredient (API) and Clinical Trials Online Training on 27 April 2026 2:00 pm

MHRA Alerts & Recalls

MHRA Safety Roundup: March 2026
31 March 2026
Field Safety Notices: 23-27 March 2026
31 March 2026
Class 2 Medicines Recall: Bio Products Laboratory Limited, Rabies, Human normal Immunoglobulin 500IU solution for Injection, EL(26)A/18
30 March 2026
Class 4 Medicines Defect Notification: Sandoz Limited, Apixaban 2.5mg and 5mg Tablets, EL(26)A/17
26 March 2026

Get In Touch

Address:
Wellesley House
10 Eelmoor Road
Farnborough
Hampshire
GU14 7QN

Phone: 01252 375362
Email: [email protected]
  • Terms and Conditions
  • Privacy Policy

Designed by Four Lakes

  • Follow
  • Follow
  • Follow
  • Follow